
Circular Genomics
Developing advanced genomic sequencing technologies for personalized medicine and research.
About
Circular Genomics is revolutionizing neurological and psychiatric care with its circular RNA platform, aiming to make brain disorders measurable and manageable. Their first product, MindLight™, is a circular RNA-based diagnostic test that predicts SSRI response in depression patients, and they are developing blood-based assays for other neurological conditions like Alzheimer's disease. The company provides actionable brain biomarker data to clinicians and payers to inform personalized treatment decisions.
Similar companies
deTechGene is a startup focused on developing advanced genetic analysis tools and platforms.
Shares Genomics, Biotech
Personalized genetic insights for health, ancestry, and wellness.
Shares Genomics, HealthTech
GeneDx is a leading provider of genomic testing and interpretation services for rare and common diseases.
Shares Genomics, HealthTech
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Shares Biotech, HealthTech
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
AI-powered spatial biology platform for precision medicine and drug development.
Shares HealthTech, Biotech
Key facts
- Website
- circulargenomics.com
- Headquarters
- Jerusalem, Israel
- Founded
- 2017
- Employees
- 18
- Total funding
- $20M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 25 Jan 2024 | Series A | $15M | Illumina Ventures, WRF Capital |
| 18 May 2022 | Undisclosed round | $5M | Mountain State Capital |
Tech stack
Detected on circulargenomics.com, last scanned 30 Oct 2026. Run your own scan
- Support
- HubSpot
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Circular Genomics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Circular Genomics is 81 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Circular Genomics raised?
Circular Genomics has raised a total of $20M in funding. The most recent round on record is Series A.
How many employees does Circular Genomics have?
Circular Genomics has approximately 18 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Circular Genomics:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

